Astrazeneca

FromAstraZeneca ([email protected])
Subject (48)Truqap improved rPFS in advanced prostate cancer
Preheader (150)Truqap combination in PTEN-deficient metastatic hormone-sensitive prostate cancer demonstrated statistically significant and clinically meaningful imp
Typography
Arial
Colors
Text Analysis
Body Words244
Subject Words7
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images7
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px876 px
X-Spam Score3.2
Preheader OptimizedNo
Timing
Day of WeekThursday
TimeEarly Morning

Truqap improved rPFS in advanced prostate cancer

Truqap combination in PTEN-deficient metastatic hormone-sensitive prostate cancer demonstrated statistically significant and clinically meaningful imp
Truqap improved rPFS in advanced prostate cancer